ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
前收盘价
US$10.48
−US$0.01 · -0.10%
盘中时间采用ET。市场数据可能有所延迟。
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
日内区间
当前US$10.48
52周区间
当前US$10.48
盘中时间采用ET。市场数据可能有所延迟。
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
日内区间
当前US$10.48
52周区间
当前US$10.48
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 3697.1万 USD | 3139万 USD | 2395.5万 USD | 2055.1万 USD | 1629.9万 USD |
| 销货成本 | 1427.9万 USD | 1226.8万 USD | 1034.1万 USD | 702万 USD | 517.6万 USD |
| 毛利 | 2269.2万 USD | 1912.2万 USD | 1361.4万 USD | 1353.1万 USD | 1112.3万 USD |
| 研究与开发 | 1389.7万 USD | 1239.2万 USD | 1170.9万 USD | 1089.4万 USD | 928.1万 USD |
| 销售、一般及管理费用 | 3295.9万 USD | 2647.6万 USD | 2435.1万 USD | 1896.9万 USD | 1521.6万 USD |
| 营业费用 | 4685.6万 USD | 3886.8万 USD | 3606万 USD | 2986.3万 USD | 2449.7万 USD |
| 利息收入 | 121.3万 USD | 87.2万 USD | 38.6万 USD | — | — |
| 利息支出 | 238.8万 USD | — | — | 8.1万 USD | 97.3万 USD |
| 折旧和摊销 | 223.7万 USD | 190.3万 USD | 145.7万 USD | 77.7万 USD | 69.2万 USD |
| 营业利润 | −2416.4万 USD | −1974.6万 USD | −2244.6万 USD | −1633.2万 USD | −1337.4万 USD |
| 净利润 | −2554万 USD | −1891.4万 USD | −2208.9万 USD | −1643.5万 USD | −1441万 USD |
公司数据更新于 2026年10月12日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2016年7月27日 | 1:40 | — | — |
已生效 2016年7月27日
1:40
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1292.66万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM769.6万0.01%787.4亿 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF529.92万0.01%954亿 USD0.05%US$235+0.80%
iShares Russell 2000 Growth ETFIWO276.64万0.02%139.17亿 USD0.24%US$356.78+0.94%
Vanguard Russell 2000 ETFVTWO245.37万0.01%180亿 USD0.06%US$112.66+0.50%
State Street SPDR S&P Health Care Equipment ETFXHE142.25万0.82%1.74亿 USD0.35%US$89.47+1.51%
State Street SPDR S&P Kensho New Economies Composite ETFKOMP128.69万0.05%26.06亿 USD0.20%US$66.35+1.13%
iShares Micro-Cap ETFIWC92.64万0.07%13.17亿 USD0.60%US$183+0.11%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
iShares Russell 2000 Growth ETFIWO
Vanguard Russell 2000 ETFVTWO
State Street SPDR S&P Health Care Equipment ETFXHE
State Street SPDR S&P Kensho New Economies Composite ETFKOMP
iShares Micro-Cap ETFIWCAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。